MRI in recurrent ovarian cancer:
An abnormal MRI examination result with a normal CA-125 value is a strong indication of residual or recurrent tumor with high accuracy, positive predictive value (6) . MRI may be superior to CT in the assessment of pelvic wall extension because of its high soft tissue contrast and multiplanar capability. Preoperative imaging is essential in patients considered for potential secondary cytoreductive surgery.
So that the presence of tumor elsewhere and any indicators of non-resectability can be identified, although invasion of the bladder and rectum by itself is not a contraindication to definitive surgical therapy (7) .
PET/CT in Recurrent Ovarian Cancer:
The sensitivity and specificity for FDG-PET/CT were 100 % and 92.5 %, respectively as reported by Nam et al. (8) .
This was higher than all other imaging modalities including US, CT, MRI, and FDG-PET alone in 50 consecutive patients a sensitivity, specificity, and accuracy of 87, 100, and 92 %, respectively, compared with 90, 61, and 89 %, respectively, for TVUS. The authors concluded that FDG-PET/CT provides additional information to TVUS for differentiating benign from malignant pelvic lesions as well as to CT for the staging of ovarian cancer patients.
These findings were further supported by a prospective study of 133 women with suspected ovarian cancer. Ovarian cancer shows variable levels of increased FDG uptake depending on the cellular composition. Abdominal or pelvic masses containing large cystic components as well as mucinous tumors will often not be metabolically active. False negative results are also seen in borderline ovarian tumor and cystadenocarcinoma of the ovary (9) .
Generally false-positive findings in the abdomen and pelvis are rare, early studies showed that in patients with pelvic masses a number of benign conditions can cause increased FDG uptake. These include benign cystadenomas, endometriosis, and inflammatory process (9) . Increased FDG uptake in normal ovaries is found in (19) . A patient with pre sacral lesions representing regional neoplastic recurrence is seen in figure (1) . 
PET/CT in detection of
. Lymphatic dissemination to the pelvic and para-aortic lymph nodes is common, . Laparoscopy is the standard diagnostic tool for the assessment of intraperitoneal infiltration but it is invasive and requires general anesthesia. 
CONCLUSION:
18F FDG PET/CT is superior to CT and MRI in diagnosis of viable recurrent and/or metastatic lesions especially peritoneal metastases in patients with rising or normal tumor marker.
